Metastatic Colorectal Cancer Global Clinical Trials Review, H2, 2017
December 2017
1293
About the Report
About the Report
Metastatic Colorectal Cancer Global Clinical Trials Review, H2, 2017
Summary
GlobalData's clinical trial report, "Metastatic Colorectal Cancer Global Clinical Trials Review, H2, 2017" provides an overview of Metastatic Colorectal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Metastatic Colorectal Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
The report provides a snapshot of the global clinical trials landscape
Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
The Report provides enrollment trends for the past five years
Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
Assists in formulating key business strategies with regards to investment
Helps in identifying prominent locations for conducting clinical trials which saves time and cost
Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
Supports understanding of trials count and enrollment trends by country in global therapeutics market
Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Products
Companies
F. Hoffmann-La Roche Ltd
Sanofi
Amgen Inc
Pfizer Inc
Bayer AG
E. Merck KG
AstraZeneca Plc
Merck & Co Inc
Bristol-Myers Squibb Co
Novartis AG
Table of Contents
Table of Contents
Table of Contents
Table of Contents
List of Tables
List of Figures
Report Guidance
GlobalData Clinical Trials Report Coverage
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Metastatic Colorectal Cancer to Oncology Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Metastatic Colorectal Cancer to Oncology Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Metastatic Colorectal Cancer Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Metastatic Colorectal Cancer
Dec 17, 2017: JHL Submits Clinical Trial Application for Proposed Bevacizumab Biosimilar
Dec 01, 2017: First patient included in Phase I study aiming at supporting expansion of global Phase III program for PledOx to include Asian patients
Nov 28, 2017: MOLOGEN to Present Poster on Lefitolimod at ESMO IO 2017
Nov 18, 2017: Study Shows New Second Line Therapy for Metastatic Colorectal Cancer is Effective and Safe
Oct 09, 2017: First patient treated with microscopic beads pre-loaded with a targeted cancer drug and visible on CT scans
Oct 04, 2017: eFFECTOR Therapeutics Initiates Dosing in Phase 2 Combination Trial of eFT508 and Avelumab in Microsatellite Stable Colorectal Cancer
Oct 03, 2017: NOXXON Publishes Preclinical Proof-of-Concept Data for Lead Compound NOX-A12 in Combination with Checkpoint Inhibitors
Sep 27, 2017: Aduro Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Personalized Immunotherapy pLADD Based on Proprietary Neoantigen Technology
Clinical Trial Profile Snapshots
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source
List of Figure
List of Figures
Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials by Region (%), 2017*
Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017*
Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017*
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017*
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017*
Metastatic Colorectal Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2017*
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017*
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017*
Proportion of Metastatic Colorectal Cancer to Oncology Clinical Trials, G7 Countries (%), 2017*
Metastatic Colorectal Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2017*
Metastatic Colorectal Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017*
Proportion of Metastatic Colorectal Cancer to Oncology Clinical Trials, E7 Countries (%), 2017*
Metastatic Colorectal Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2017*
Metastatic Colorectal Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017*
Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2017*
Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2017*
Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2017*
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2017*
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016
Metastatic Colorectal Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017*
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2017*
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017*
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017*
GlobalData Methodology
List of Table
List of Tables
Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials by Region, 2017*
Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017*
Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017*
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017*
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2017*
Metastatic Colorectal Cancer Therapeutics Clinical Trials, North America, Top Countries, 2017*
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017*
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017*
Proportion of Metastatic Colorectal Cancer to Oncology Clinical Trials, G7 Countries (%), 2017*
Metastatic Colorectal Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2017*
Metastatic Colorectal Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017*
Proportion of Metastatic Colorectal Cancer to Oncology Clinical Trials, E7 Countries (%), 2017*
Metastatic Colorectal Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2017*
Metastatic Colorectal Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017*
Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials by Phase, 2017*
Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2017*
Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2017*
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2017*
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016
Metastatic Colorectal Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017*
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2017*
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017*
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017*
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.